PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States of America.\', \'Virginia Mason Franciscan Health, Seattle, Washington, United States of America.\', \'Department of Medicine, University of Washington, Seattle, Washington, United States of America.\', \'Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.\', \'Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.\', \'Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, United States of America.\', \'Department of Global Health, University of Washington, Seattle, Washington, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.ppat.1010203
?:doi
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 34965282
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
?:title
  • Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all